The Oncology Institute Inc./$TOI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About The Oncology Institute Inc.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
Ticker
$TOI
Sector
Primary listing
Employees
641
Headquarters
Website
TOI Metrics
BasicAdvanced
$518m
-
-$0.37
0.36
-
Price and volume
Market cap
$518m
Beta
0.36
52-week high
$5.58
52-week low
$2.02
Average daily volume
1.9m
Financial strength
Current ratio
1.473
Quick ratio
1.131
Long term debt to equity
-598.545
Total debt to equity
-644.231
Interest coverage (TTM)
-2.93%
Profitability
EBITDA (TTM)
-25.909
Gross margin (TTM)
15.12%
Net profit margin (TTM)
-7.97%
Operating margin (TTM)
-5.99%
Effective tax rate (TTM)
0.30%
Revenue per employee (TTM)
$850,000
Management effectiveness
Return on assets (TTM)
-12.30%
Return on equity (TTM)
775.91%
Valuation
Price to revenue (TTM)
0.936
Price to book
-31.8
Price to tangible book (TTM)
-15.31
Price to free cash flow (TTM)
-19.845
Free cash flow yield (TTM)
-5.04%
Free cash flow per share (TTM)
-0.261
Growth
Revenue change (TTM)
35.37%
Earnings per share change (TTM)
-47.19%
3-year revenue growth (CAGR)
25.90%
3-year earnings per share growth (CAGR)
-22.24%
TOI News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs